Latest News

India

India: Peer-reviewed study of health care workers demonstrates that ivermectin can prevent Covid infection

Two doses (300 μg/kg/dose in a gap of 72 hours) of ivermectin chemoprophylaxis reduced COVID-19 infection by 83% among HCWs for one month. Ivermectin is a safe and effective strategy to prevent COVID-19, in the containment of pandemic alongside vaccine. Further research is required to guide the frequency of chemoprevention, acceptability, and cost-effectiveness in the community setting.

Read More »
blank
Grenada

Letter to Grenada’s Health Minister to recommend ivermectin

Over the past four months, E-BMC Ltd has been working together with the FLCCC to encourage governments around the world to adopt re-purposed existing drugs for the early treatment of
covid-19. One such drug is Ivermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections. properties as well. E-BMC Ltd’s comprehensive meta-analysis, which has now been published in the peer-reviewed American Journal of Therapeutics, shows that “moderate-certainty evidence” points to a substantial reduction in Covid-19 related deaths with the use of ivermectin.

Read More »
blank
A Patient Story

Chronicle of a Covid death foretold – the battle for early treatment being waged behind enemy lines

Borody’s ivermectin triple therapy prophylactic is the perfect solution. It reduces transmission immediately, regardless of the variant, by preventing the virus from entering a person’s cells. It also shortens time spent in quarantine and reduces transmission to close contacts. Early treatment dramatically reduces hospitalisation and mortality and would rapidly end the Sydney wave, as similar therapies did in Mexico and India. It would also put an end to any need for masks and lockdowns.

Read More »
blank
Ivermectin

Big Ivermectin News for Jamaica

Jamaica’s Minister of Health and Wellness recently signed the import permit to allow stocks of Ivermectin into Jamaica. This comes after rising cases due to the COVID-19 Delta variant and increasing public pressure. Supplies of the generic, anti-parasitic drug will come from Edenbridge Pharmaceuticals in New Jersey and be distributed by LASCO Pharmaceuticals in Jamaica. In general, doctors are pleased about having Ivermectin as an option.

Read More »
blank
Australia

Ivermectin. It’s as Aussie as Vegemite. The path out of the pandemic is under our noses.

It’s all so cruel and unnecessary. With or without Professor Skerritt, if doctors prescribed ivermectin therapy for every person who tests positive, and wants it, and for their close contacts, the Delta wave would wash away. Offer it to the vaccine-hesitant and anyone seeking protection until they were vaccinated, and we could reopen our borders. How apposite that the escape route out of our pandemic prison could be as Aussie as Vegemite.

Read More »

About The Foundation

Clive-Palmer_res (9)

The Palmer Foundation is the philanthropic entity owned by the Palmer family, headed by Clive Palmer. 

The Palmer Foundation is a private entity that engages in charitable projects that enable better welfare of others, and society as a whole. 

The foundations most recent endeavour revolves around the response to, and action on the COVID-19 Virus pandemic for the treatment of all Australians in need.

Click here to get the background on The Palmer Foundations COVID-19 Response.

 

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Popular Stories

blank
Australia

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »
blank
Australia

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »